Moderna Inc
MRNA
ISIN null / Valor 44811242
Moderna Inc
UMushroom community rating:
About company
Moderna, Inc. is a publicly traded biotechnology company (NASDAQ: MRNA) headquartered in Cambridge, Massachusetts, that develops and commercializes medicines and vaccines based on messenger RNA (mRNA) technology. Founded in 2010, the firm built an mRNA platform that pairs synthetic mRNA constructs with lipid nanoparticle delivery to produce target proteins in patients, and its highest-profile product is the COVID-19 vaccine Spikevax, which has driven significant commercial revenue and government contracts. Beyond COVID-19, Moderna maintains a broad pipeline across infectious disease vaccines, oncology (including personalized cancer vaccine programs), rare and cardiometabolic diseases, and other therapeutic areas, and it has invested in clinical development, scale-up of manufacturing capacity, and partnerships with public and private research organizations to advance and commercialize its candidates.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
89828 M
Market cap (USD)
28,947,262
Daily traded volume (Shares)
40.5 / 38.89
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Mihai Rosu
Amish Guruv
Gustav Michalke
EQUITIES OF THE SAME SECTOR
